A detailed history of Cipher Capital LP transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Cipher Capital LP holds 10,717 shares of AMLX stock, worth $53,156. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,717
Holding current value
$53,156
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.71 - $19.57 $29,043 - $209,731
10,717 New
10,717 $30,000

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Cipher Capital LP Portfolio

Follow Cipher Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cipher Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Cipher Capital LP with notifications on news.